Tumor irradiation induces damage and death of cancer cells resulting in the surface exposure of immunogenic molecules as well as the release of damage associated molecular patterns (DAMPs) such as ATP or High-Mobility-Group-Protein B1 (HMGB1), and potentially tumor antigens, to activate innate and adaptive immune responses (80). The gene discussed is HMGB1; the disease is cancer.